| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |